Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Mario Torso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Brain Diagnostics Ltd, Oxford, UK. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Disease Progression, Dementia, Diffusion Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND This study evaluates the capability of cortical microstructural measures from diffusion magnetic resonance imaging (MRI) to predict progression from mild cognitive impairment (MCI) to dementia, compared to commonly used macrostructural measures. Identification of high‐risk individuals can support both clinical practice and trials. METHODS Structural and diffusion MRI scans of 826 participants from the National Alzheimer's Coordinating Center (NACC) were analyzed to extract macrostructural measures and three minicolumn‐related diffusivity metrics: AngleR, PerpPD + , and ParlPD. Kaplan–Meier survival analysis was used to investigate time to progression to dementia, with participants stratified by biomarker metrics. RESULTS Cortical diffusivity (PerpPD + in medial–temporal and connected regions) outperformed hippocampal volume, cortical volume, and cortical thickness in Kaplan–Meier survival analysis, predicting faster conversion to dementia. DISCUSSION Cortical microstructural measures from diffusion MRI provide powerful biomarkers for predicting progression from MCI to dementia, offering enhanced prognostic capabilities that could support earlier intervention strategies in clinical practice and improve the power of clinical trials. Highlights Cortical minicolumn‐related diffusivity metrics measure neurodegeneration. We compare the predictive value of magnetic resonance imaging (MRI) measures for mild cognitive impairment to dementia progression. Microstructural cortical disarray outperforms macrostructural markers. These results support using diffusion MRI biomarkers to identify and monitor at‐risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oxford Brain Diagnostics Ltd, Oxford, UK.
ORCID-Profile: Mario Torso, Gerard R Ridgway
Förderung
- NIA NIH HHS
Zitieren
APA
Torso, M., Khosropanah, P., Chance, S. A., & Ridgway, G. R. (2025). Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70310
Vancouver
Torso M, Khosropanah P, Chance SA, Ridgway GR. Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70310
BibTeX
@article{Torso2025,
author = {Torso, Mario and Khosropanah, Pegah and Chance, Steven A and Ridgway, Gerard R},
title = {Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70310}
}
EUVIMED